Direct intracoronary delivery of tirofiban during primary percutaneous coronary intervention for ST-elevation myocardial infarction  

作　　者：SHEN Wei-feng 

机构地区：[1]Department of Cardiology,Ruijin Hospital,Institute of Cardiovascular Disease,Jiao Tong University School of Medicine,Shanghai 200025,China

出　　处：《Chinese Medical Journal》2012年第1期3-6,共4页中华医学杂志（英文版）

摘　　要：ST-segment elevation myocardial infarction （STEMI） is usually caused by acute occlusion of an infarct-related coronary artery （IRA）, resulting from rupture or erosion of an atherosclerotic plaque and subsequent platelet aggregation and thrombosis.l3 Prompt reperfusion is the key aspect of the optimal management,.7 and timely expert primary percutaneous coronary intervention （PCI） becomes the best reperfusion strategy with respect to improvement in survival and reduction of combined clinical endpoints in the treatment of STEMI.ST-segment elevation myocardial infarction （STEMI） is usually caused by acute occlusion of an infarct-related coronary artery （IRA）, resulting from rupture or erosion of an atherosclerotic plaque and subsequent platelet aggregation and thrombosis.l3 Prompt reperfusion is the key aspect of the optimal management,.7 and timely expert primary percutaneous coronary intervention （PCI） becomes the best reperfusion strategy with respect to improvement in survival and reduction of combined clinical endpoints in the treatment of STEMI.

关 键 词：tirofiban primary percutaneous coronary intervention ＂ ST-elevation myocardial infarction 

分 类 号：Q954.561[生物学—动物学] X591[环境科学与工程—环境工程]